See how BioDlink’s digital-intelligence platform is driving three major improvements in lyophilization workflows.

Critical illness poses a significant global health challenge, disproportionately affecting low- and middle-income countries ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Apple's highly anticipated foldable iPhone could face supply shortages into 2027 despite a planned launch next year, ...

The Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamic activity of ACCG-2671 in both healthy volunteers and individuals with obesity. The study will ...

(TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, has signed a three-year ...

Vaxcyte aims to revolutionize the pneumococcal vaccine market with VAX-31. Click here to read an analysis of PCVX stock now.

Chaired by globally renowned nuclear medicine expert Prof. Ken Herrmann, M.D. Other Board members James Cook, Jason Lewis, Ph.D., and Michael ...

Altair, a global leader in computational intelligence and now part of leading technology company, Siemens, announced the ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Data protection concerns are especially acute in fields dealing with sensitive information, such as finance and medical ...

WearTech Labs, one of SFU’s Core Facilities, today celebrated its grand opening with an event at SFU’s Surrey campus. The event marks the launch of the final lab within the facility, which offers a ...